Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune monitoring from the E1912 trial is a research paper published in Blood (2023). On theSindex it has a DataRank of 0. It has been cited 21 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: U10 CA180820
NCI NIH HHS
Grant: UG1 CA232760
NCI NIH HHS
Grant: UG1 CA233290
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: R01 CA193541
NCI NIH HHS
Grant: R01 CA251801
NCI NIH HHS
Grant: U24 CA196172
NCI NIH HHS
Grant: U10 CA180794
Fields of Study
MeSH Terms